An Open-label Phase 1/2 Multicentre Study to Evaluate the Safety, Tolerability and Efficacy of RTX001 Autologous Macrophages in Participants with Liver Cirrhosis who have Hepatic Decompensation (EMERALD)

• Protocol code: RTX001-002
• EudraCT code: No aplica
• Research group: Liver Diseases
• Service: Hepatology
• Principal investigator:  Pons Delgado, Mònica
• Pathology: Tumors
• Phase: Fase I